Dangerous Synthetic Drug Control Act of 2016

H.R.6-21st Century Cures Act H.R.33-Protecting Volunteer Firefighters and Emergency Responders Act H.R.34-21st Century Cures Act H.R.290-Creating Access to Rehabilitation for Every Senior (CARES) Act of 2015 H.R.293-To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes. H.R.398-Trafficking Awareness Training for Health Care Act H.R.639-Improving Regulatory Transparency for New Medical Therapies Act H.R.647-Access to Life-Saving Trauma Care for All Americans Act H.R.648-Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R.836-Health Care Safety Net Enhancement Act H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1190-Protecting Seniors Access to Medicare Act of 2015 H.R.1571-Improving Access to Medicare Coverage Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1818-Veteran Emergency Medical Technician Support Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.2050-Middle Class Health Benefits Tax Repeal Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2366-Field EMS Modernization and Innovation Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2603-Saving Lives, Saving Costs Act H.R.2646-Helping Families in Mental Health Crisis Act of 2015 H.R.2799-Furthering Access to Stroke Telemedicine (FAST) Act H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.2948-Medicare Telehealth Parity Act of 2015 H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3299-Strengthening Public Health Emergency Response Act H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3681-Improving Access to Emergency Psychiatric Care Act H.R.3682-Reducing Employer Burdens, Unleashing Innovation, and Labor Development Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R.3770-End Surprise Billing Act of 2015 H.R.3865-Cradle Act H.R.4059-Medicare Choices Empowerment and Protection Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4150-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 H.R.4435-Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 H.R.4771-Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016 H.R.4732-Advancing Medical Resident Training in Community Hospitals Act of 2016 H.R.5243-Zika Response Appropriations Act H.R.5273-Helping Hospitals Improve Patient Care H.R.5284-World's Greatest Healthcare Plan Act of 2016 H.R.5547-Health Care Price Transparency Promotion Act of 2016 H.Res.877-Encouraging each State to enact legislation that increases the likelihood of survival after sudden cardiac arrest in our Nation's schools. S.141-Protecting Seniors Access to Medicare Act of 2015 S.425-Homeless Veterans' Reintegration Programs Reauthorization Act of 2015 S.453-Veteran Emergency Medical Technician Support Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.599-Improving Access to Emergency Psychiatric Care Act S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.711-Mental Health First Act of 2015 S.763-Trauma Systems and Regionalization of Emergency Care Reauthorization Act S.884-Health Care Safety Net Enhancement Act S.843-Improving Access to Medicare Coverage Act of 2015 S.954-FDA Accountability for Public Safety Act S.993-Comprehensive Justice and Mental Health Act of 2015 S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.1450-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act S.1452-Veterans Emergency Health Safety Net Expansion Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1465-Furthering Access to Stroke Telemedicine (FAST) Act S.1475-Saving Lives, Saving Costs Act S.1549-Care Planning Act of 2015 S.1648-Rural Emergency Acute Care Hospital (REACH) Act S.1654-Overdose Prevention Act S.1693-To amend title 38, United States Code, to expand eligibility for reimbursement for emergency medical treatment to certain veterans that were unable to receive care from the Department of Veterans Affairs in the 24-month period preceding the furnishing of such emergency treatment, and for other purposes. S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015 S.1893-Mental Health Awareness and Improvement Act of 2015 S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.1945-Mental Health Reform Act of 2015 S.2002-Mental Health and Safe Communities Act of 2015 S.2045-Middle Class Health Benefits Tax Repeal Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2297-Medicare Choices Empowerment and Protection Act S.2525-Expand Excellence in Mental Health Act S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2597-Medicare Mental Health Access Act S.2671-Advancing Medical Resident Training in Community Hospitals Act of 2016 S.2680-Mental Health Reform Act of 2016 S.2687-Plan of Safe Care Improvement Act S.2932-Protecting Patient Access to Emergency Medications Act of 2016 S.2985-World's Greatest Healthcare Plan Act of 2016 S. 3407, Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths (MISSION ZERO) Act P.L.114-10-Medicare Access and CHIP Reauthorization Act of 2015 P.L.114-324-Justice for All Reauthorization Act

Client expense: $462,139 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support S. 178. Oppose mandatory minimum sentences Support restoring proportionality to drug sentencing. Support promotion and adequately fund recidivism reduction and reentry programming. Support making sentencing reductions retroactive. Support expanding the Bureau of Prison's Compassionate Release Program. Support expanding time credits for good behavior. Comments on Juvenile Justice Provisions of ESSA implementation: urge prompt and appropriate access to a quality education and the success of students involved in and reentering from the juvenile justice system through the development of effective regulations and guidance as well as other activities to fully implement reauthorization of Title I, Part D in ESSA. Support the BOP's providing voter eligibility information to all upon release from prison or jail. Support continued federal funding of innocence and forensic science programs at the Department of Justice and the National Institute of Standards and Technology at the Department of Commerce in the final FY 2017 appropriations bill. Support S. 502/H.R. 920 Support H.R. 1232 Support a significant increase funding for federal programs that address domestic violence, sexual assault, dating violence and stalking Support H.R. 1255 Support H.R. 1253 / S. 467 Support S. 772 / H.R. 1459 Support requiring universal background checks on all gun sales Support a ban on military-style semi automatic assault guns Support a ban on high capacity ammunition clips Support tough new criminal penalties for straw purchasers and gun traffickers Support "no fly-no buy" gun proposals Support executive action to ensure that both federal agencies and federal contractors are leading the way to making employment opportunities available for qualified job-seekers who have an arrest or conviction in their past. Support S. 295 Oppose the federal death penalty support federal support for local law enforcement agencies to purchase video surveillance equipment such as body cameras, gun cameras, dashboard cameras, and taser cameras Support the establishment of independent, effective civilian review boards for all levels of law enforcement Support legislation to review racial disparities in decisions by prosecutors Support the creation of uniform use of force standards for law enforcement officials. Support aggressive, comprehensive reform of civil asset forfeiture laws. Oppose H.R. 1927 Promote employment of body worn cameras by law enforcement officers which also promotes and protect civil rights and civil liberties. Support S. 1119 / H.R. 2330 Support S. 1133 / H.R.2087 Support HR 2875 / s. 2168 Support HR 1933 / S 1056 Support HR 1124 Support HR 2197/ S. 1770 Support HR 2944 Support S. 1169 / HR 2728 Support S. 1513 / H.R. 3406; support full funding for the Second Chance Act Support H Res 262 Support HR 2302 Support H Res 295 Support the inclusion of funding for Juvenile Justice Programs through the Juvenile Justice and Delinquency Prevention Program (JJDPA) in the House Appropriations Bill for the Departments of Commerce, Justice, and Science and related Agencies for FY 2017 Support S. 255 / H.R. 540 Oppose a new five-year mandatory minimum sentence for illegal reentry. Support S 2168 Support HR 1124 Support HR 3470 / S 2021 Urge Congress to allocate a sufficient new 302(b) allocation for the FY 2017 Commerce, Justice, Science and Related Agencies appropriations bill so that criminal and juvenile justice grant programs can be adequately funded. Support HR 2521 Support strengthening and passing H.R. 3713 / s 2123 Oppose anti-Muslim, Islamophobic rhetoric, actions, and legislation. Ensure that the Department of Justice is as tough as possible in protecting an individual's right to vote in light if the elimination of Se4ction V of the 1065 Voting Rights Act Oppose HR 712 Oppose HR 1927 Support Cornyn / Leahy amendment to the Justice for All Act which strengthens the Prison Rape Elimination Act Support the FCC exerting its authority and safeguarding consumers both inside and outside prisons by addressing the following issues put forward in the most recent NPRM: 1) advanced communications, including video visitation; 2) international calling rates; 3) the communications rights of deaf, hard of hearing, and disabled inmates; 4) ensuring the limits on ancillary fees are effective for all communications; and 5) regular data collection in the prison communications industry. Oppose H.R. 766. Support Operation Choke Point. Support President Obama speaking at the UNGASS on the world drug problem. Support providing the FY17 Commerce, Justice, Science, and Related Agencies Appropriations (CJS) bill with the highest 302(b) allocation possible to ensure adequate funding for key criminal and juvenile justice grant programs within the bill.Support a strong implementation of the Holder Rule, which says that when a seller of a good or service originates or helps arrange credit, the consumer is allowed to raise the sellers misconduct as a basis for bringing claims or defenses against the entity holding the debt. Support the investigation into the continued and largely unregulated use of Stingrays by law enforcement officials, to remedy the lack of data and transparency about these devices, and to act swiftly to prevent the disproportionate harms that the use of these devices by law enforcement officials can pose to historically disadvantaged communities. Support OJP to a) condition federal criminal justice grants on data collection and reporting on police-civilian encounters and b) provide regulations on the implementation of the Deaths in Custody Reporting Act (DCRA). Support H.R. 4364 Oppose refusal by some Senators to give fair consideration to any Supreme Court nomination until after the next President is sworn into office on January 20, 2017. Support funding for several programs related to child labor, forced labor, and human trafficking in FY 2017 Labor-HHS-Education funding bill. Support funding for several programs related to child labor, forced labor, and human trafficking in FY 2017 Transportation-HUD funding bill. Specifically, $33,000,000 to fund comprehensive continuum of care projects for homeless and runaway youth. Support a stronger US position at the UN General Assembly on the World Drug Problem on: acknowledging the ramifications of new drug policies; standing up for human rights; calling for a people-centered approach to drug policy; taking a stronger stance on criminal justice reform; and ensuring an open dialog between all interested parties. Support adequate funding for critical juvenile justice and delinquency prevention programs in the final Fiscal Year 2017 Commerce, Justice, Science, and Related Agencies (CJS) Appropriations bill. Support adequate funding for innocence and forensic science programs in FY 17. Specifically, $5 million for the DoJ Wrongful Conviction Review Program; $5 million for the Kirk Bloodsworth Post-Conviction DNA Testing Program; $14 million for the Paul Coverdell Forensic Sciences Improvement Grant Program; $5 million for the DoJ National Commission on Forensic Science; and $15 million for NIST Oppose S 2576 Support an increase in funding for programs that serve victims of sexual assault and domestic violence (including VAWA, VOC, and FVPSA) in FY 2017. Support HR 4611 Support the Equal Justice Under Law Act. Support H.R. 3406 Support S 2123 / HR 3713 with the following improvements: The increased use of evidence-based sentencing alternatives, including drug, Veteran, and mental health courts; Reducing recidivism through educational and job training opportunities for prisoners while they are incarcerated (this includes restoring Pell grant eligibility to prisoners); A concentration on using prison space for career or violent criminals; The elimination of all mandatory minimum sentences, and an increase in judicial discretion; and In depth reports to Congress by the Department of Justice on the extent to which reforms have addressed both over-incarceration and racial disparities. Oppose backlog of judicial nominees Support Sec. Burwell speaking at UNGASS Support executive order prohibiting federal contractors from asking about past criminal records on job application Oppose current policy which allows children to go through the immigration court process without the benefit of counsel. Oppose HR 1927 Support Moore (WI) equal pay and fair housing amendments to HR 1927 Support Conyers amendment to HR 1927 Support rule banning forced arbitration for students victimized by for-profit institutions Oppose Anti-Transgender Initiatives Support proposed DoE / DoJ guidance on Title IX on the rights of trans students in schools Support H.R.5100, S.2874 Conditional support for HR 5283. Support bringing HR 5283 to the floor for consideration prior to Summer break and strengthening it to include the Equitable Sharing program Oppose Ayotte amendments S. AMDT. 4082 and S. AMDT. 4083 to S. 2943. Support investigating the arrest and indictment of disproportionately Asian American scientists Support treating the drug problem as a health issue Support the Baldwin, Mikulski, and Hirono Amendment to the FY 2017 Commerce, Justice, Science and Related Agencies Appropriations Act which would add necessary funds for the Justice Departments Civil Rights Division (CRT) and its Community Relations Service (CRS) to prevent hate crimes and to effectively investigate and prosecute them when they occur. Support OPM proposed rule on Recruitment, Selection, and Placement (General) and Suitability Support HR 4752 Support S.1513/H.R.3406. Support Senate hearings on President Obama's Supreme Court nominee Support HR 5124 Support HR 2302 Support S 2584 / HR 5067 Support greater accountability of schools serving students involved in the juvenile justice system in ESSA regulations. Support Department of Justice efforts to establish standards, grounded in sound science, for laboratory reports and testimony based on specific forensic disciplines. Oppose predictive policing Support the conditioning of federal criminal justice grants on data collection and reporting on police-civilian encounters under the promulgation of the Death In Custody Reporting Act Support funding levels for innocence and forensic science programs as found in the Senate FY17 Commerce, Justice, Science, and Related Agencies Appropriations bill. Support HR 5963 Support strong, enforceable guidelines to ensure that School Resource Officers respect the civil rights of students. Support HR 6211 Support S. 2854 / H.R. 5067 Support S. 3144 / H.R. 5124 Support HR 4754 Support S.1513/H.R.3406 Oppose HR 3537 Oppose HR 6158 Support increased oversight of the use of the FBIs face recognition technology Support S 2123; support it being considered during lame duck Support hearings and a vote on Supreme Court nominee Merrick Garland ASAP Oppose Jeff Sessions for US Attorney General Support expansion of presidential clemency of non-violent drug offenders Support HR 5963 Support S 2854 Oppose HR 3537 Support S.1513/H.R.3406.

Client expense: $68,750 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Alcohol Tobacco Firearms & Explosives, Bureau of Prisons (BOP), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Council of Economic Advisers (CEA), Defense, Dept of (DOD), Education, Dept of, Election Assistance Commission (EAC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Housing Finance Agency (FHFA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Credit Union Administration (NCUA), Natl Institute of Standards & Technology (NIST), Natl Telecommunications & Information Administration (NTIA), Office of Faith-Based & Community Initiatives, Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

H.R.3537, The Synthetic Drug Control Act H.R, 4229, The Protecting Our Youth from Dangerous Synthetic Drugs Act S. 36, Protecting Our Youth from Dangerous Synthetic Drugs Act

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment Biomedical innovation legislation (Senate draft) H.R.6, 21st Century Cures Act, Medical research issues. H.R.34, 21st Century Cures Act, Medical research issues. Drug abuse research and treatment related issues: H.R.3537, Synthetic Drug Control Act of 2015 Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016 S.3224/H.R.5934, Dangerous Synthetic Drug Control Act of 2016 S.36/H.R.4229, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

HR. 8 North American Energy Security and Infrastructure Act H.R. 1806 America COMPETES Act Reauthorization Act H.R. 3537 Synthetic Drug Control Act H.R. 4783 Commercializing on Small Business Innovation Act H.R. 4909 National Defense Authorization Act H.R. 5583 University Regulation Streamlining and Harmonization Act S. 185 Promise for Antibiotics and Therapeutics for Health Act S. 771 Manufacturing Universities Act S. 2012 Energy Policy and Modernization Act S. 2089 American Energy Innovation Act S. 2658 Federal Aviation Administration (FAA) Modernization Act S. 2713 Advancing Precision Medicine Act of 2016 S. 2742 Promoting Biomedical Research and Public Health for Patients Act S. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act S. 2793 SBIR/STTR Reauthorization Act S. 2812 SBIR and STTR Reauthorization and Improvement Act S. 2898 Small Business National Security Innovation Act S. 2943 National Defense Authorization Act S. 3084, American Innovation and Competitiveness Act S. 3224 Synthetic Drug Control Act S. 3346 The NASA Transition Authorization Act -- regarding research-related funding and policy issues affecting higher education institutions

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR. 8 North American Energy Security and Infrastructure Act H.R. 1806 America COMPETES Act Reauthorization Act H.R. 3537 Synthetic Drug Control Act H.R. 4783 Commercializing on Small Business Innovation Act H.R. 4909 National Defense Authorization Act H.R. 5583 University Regulation Streamlining and Harmonization Act S. 3346 The NASA Transition Authorization Act S. 185 Promise for Antibiotics and Therapeutics for Health Act S. 771 Manufacturing Universities Act S. 2012 Energy Policy and Modernization Act S. 2089 American Energy Innovation Act S. 2658 Federal Aviation Administration (FAA) Modernization Act S. 2713 Advancing Precision Medicine Act of 2016 S. 2742 Promoting Biomedical Research and Public Health for Patients Act S. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act S. 2793 SBIR/STTR Reauthorization Act S. 2812 SBIR and STTR Reauthorization and Improvement Act S. 2898 Small Business National Security Innovation Act S. 2943 National Defense Authorization Act S. 3084 American Innovation and Competitiveness Act S. 3224 Synthetic Drug Control Act -- regarding research-related funding and policy issues affecting higher education institutions

Client expense: $15,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3537, The Synthetic Drug Control Act H.R, 4229, The Protecting Our Youth from Dangerous Synthetic Drugs Act S. 36, Protecting Our Youth from Dangerous Synthetic Drugs Act

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support S. 178. Oppose mandatory minimum sentences Support restoring proportionality to drug sentencing. Support promotion and adequately fund recidivism reduction and reentry programming. Support making sentencing reductions retroactive. Support expanding the Bureau of Prison's Compassionate Release Program. Support expanding time credits for good behavior. Comments on Juvenile Justice Provisions of ESSA implementation: urge prompt and appropriate access to a quality education and the success of students involved in and reentering from the juvenile justice system through the development of effective regulations and guidance as well as other activities to fully implement reauthorization of Title I, Part D in ESSA. Support the BOP's providing voter eligibility information to all upon release from prison or jail. Support continued federal funding of innocence and forensic science programs at the Department of Justice and the National Institute of Standards and Technology at the Department of Commerce in the final FY 2017 appropriations bill. Support S. 502/H.R. 920 Support H.R. 1232 Support a significant increase funding for federal programs that address domestic violence, sexual assault, dating violence and stalking Support H.R. 1255 Support H.R. 1253 / S. 467 Support S. 772 / H.R. 1459 Support requiring universal background checks on all gun sales Support a ban on military-style semi automatic assault guns Support a ban on high capacity ammunition clips Support tough new criminal penalties for straw purchasers and gun traffickers Support "no fly-no buy" gun proposals Support executive action to ensure that both federal agencies and federal contractors are leading the way to making employment opportunities available for qualified job-seekers who have an arrest or conviction in their past. Support S. 295 Oppose the federal death penalty support federal support for local law enforcement agencies to purchase video surveillance equipment such as body cameras, gun cameras, dashboard cameras, and taser cameras Support the establishment of independent, effective civilian review boards for all levels of law enforcement Support legislation to review racial disparities in decisions by prosecutors Support the creation of uniform use of force standards for law enforcement officials. Support aggressive, comprehensive reform of civil asset forfeiture laws. Oppose H.R. 1927 Promote employment of body worn cameras by law enforcement officers which also promotes and protect civil rights and civil liberties. Support S. 1119 / H.R. 2330 Support S. 1133 / H.R.2087 Support HR 2875 / s. 2168 Support HR 1933 / S 1056 Support HR 1124 Support HR 2197/ S. 1770 Support HR 2944 Support S. 1169 / HR 2728 Support S. 1513 / H.R. 3406; support full funding for the Second Chance Act Support H Res 262 Support HR 2302 Support H Res 295 Support the inclusion of funding for Juvenile Justice Programs through the Juvenile Justice and Delinquency Prevention Program (JJDPA) in the House Appropriations Bill for the Departments of Commerce, Justice, and Science and related Agencies for FY 2017 Support S. 255 / H.R. 540 Oppose a new five-year mandatory minimum sentence for illegal reentry. Support S 2168 Support HR 1124 Support HR 3470 / S 2021 Urge Congress to allocate a sufficient new 302(b) allocation for the FY 2017 Commerce, Justice, Science and Related Agencies appropriations bill so that criminal and juvenile justice grant programs can be adequately funded. Support HR 2521 Support strengthening and passing H.R. 3713 / s 2123 Oppose anti-Muslim, Islamophobic rhetoric, actions, and legislation. Ensure that the Department of Justice is as tough as possible in protecting an individual's right to vote in light if the elimination of Se4ction V of the 1065 Voting Rights Act Oppose HR 712 Oppose HR 1927 Support Cornyn / Leahy amendment to the Justice for All Act which strengthens the Prison Rape Elimination Act Support the FCC exerting its authority and safeguarding consumers both inside and outside prisons by addressing the following issues put forward in the most recent NPRM: 1) advanced communications, including video visitation; 2) international calling rates; 3) the communications rights of deaf, hard of hearing, and disabled inmates; 4) ensuring the limits on ancillary fees are effective for all communications; and 5) regular data collection in the prison communications industry. Oppose H.R. 766. Support Operation Choke Point. Support President Obama speaking at the UNGASS on the world drug problem. Support providing the FY17 Commerce, Justice, Science, and Related Agencies Appropriations (CJS) bill with the highest 302(b) allocation possible to ensure adequate funding for key criminal and juvenile justice grant programs within the bill.Support a strong implementation of the Holder Rule, which says that when a seller of a good or service originates or helps arrange credit, the consumer is allowed to raise the sellers misconduct as a basis for bringing claims or defenses against the entity holding the debt. Support the investigation into the continued and largely unregulated use of Stingrays by law enforcement officials, to remedy the lack of data and transparency about these devices, and to act swiftly to prevent the disproportionate harms that the use of these devices by law enforcement officials can pose to historically disadvantaged communities. Support OJP to a) condition federal criminal justice grants on data collection and reporting on police-civilian encounters and b) provide regulations on the implementation of the Deaths in Custody Reporting Act (DCRA). Support H.R. 4364 Oppose refusal by some Senators to give fair consideration to any Supreme Court nomination until after the next President is sworn into office on January 20, 2017. Support funding for several programs related to child labor, forced labor, and human trafficking in FY 2017 Labor-HHS-Education funding bill. Support funding for several programs related to child labor, forced labor, and human trafficking in FY 2017 Transportation-HUD funding bill. Specifically, $33,000,000 to fund comprehensive continuum of care projects for homeless and runaway youth. Support a stronger US position at the UN General Assembly on the World Drug Problem on: acknowledging the ramifications of new drug policies; standing up for human rights; calling for a people-centered approach to drug policy; taking a stronger stance on criminal justice reform; and ensuring an open dialog between all interested parties. Support adequate funding for critical juvenile justice and delinquency prevention programs in the final Fiscal Year 2017 Commerce, Justice, Science, and Related Agencies (CJS) Appropriations bill. Support adequate funding for innocence and forensic science programs in FY 17. Specifically, $5 million for the DoJ Wrongful Conviction Review Program; $5 million for the Kirk Bloodsworth Post-Conviction DNA Testing Program; $14 million for the Paul Coverdell Forensic Sciences Improvement Grant Program; $5 million for the DoJ National Commission on Forensic Science; and $15 million for NIST Oppose S 2576 Support an increase in funding for programs that serve victims of sexual assault and domestic violence (including VAWA, VOC, and FVPSA) in FY 2017. Support HR 4611 Support the Equal Justice Under Law Act. Support H.R. 3406 Support S 2123 / HR 3713 with the following improvements: The increased use of evidence-based sentencing alternatives, including drug, Veteran, and mental health courts; Reducing recidivism through educational and job training opportunities for prisoners while they are incarcerated (this includes restoring Pell grant eligibility to prisoners); A concentration on using prison space for career or violent criminals; The elimination of all mandatory minimum sentences, and an increase in judicial discretion; and In depth reports to Congress by the Department of Justice on the extent to which reforms have addressed both over-incarceration and racial disparities. Oppose backlog of judicial nominees Support Sec. Burwell speaking at UNGASS Support executive order prohibiting federal contractors from asking about past criminal records on job application Oppose current policy which allows children to go through the immigration court process without the benefit of counsel. Oppose HR 1927 Support Moore (WI) equal pay and fair housing amendments to HR 1927 Support Conyers amendment to HR 1927 Support rule banning forced arbitration for students victimized by for-profit institutions Oppose Anti-Transgender Initiatives Support proposed DoE / DoJ guidance on Title IX on the rights of trans students in schools Support H.R.5100, S.2874 Conditional support for HR 5283. Support bringing HR 5283 to the floor for consideration prior to Summer break and strengthening it to include the Equitable Sharing program Oppose Ayotte amendments S. AMDT. 4082 and S. AMDT. 4083 to S. 2943. Support investigating the arrest and indictment of disproportionately Asian American scientists Support treating the drug problem as a health issue Support the Baldwin, Mikulski, and Hirono Amendment to the FY 2017 Commerce, Justice, Science and Related Agencies Appropriations Act which would add necessary funds for the Justice Departments Civil Rights Division (CRT) and its Community Relations Service (CRS) to prevent hate crimes and to effectively investigate and prosecute them when they occur. Support OPM proposed rule on Recruitment, Selection, and Placement (General) and Suitability Support HR 4752 Support S.1513/H.R.3406. Support Senate hearings on President Obama's Supreme Court nominee Support HR 5124 Support HR 2302 Support S 2584 / HR 5067 Support greater accountability of schools serving students involved in the juvenile justice system in ESSA regulations. Support Department of Justice efforts to establish standards, grounded in sound science, for laboratory reports and testimony based on specific forensic disciplines. Oppose predictive policing Support the conditioning of federal criminal justice grants on data collection and reporting on police-civilian encounters under the promulgation of the Death In Custody Reporting Act Support funding levels for innocence and forensic science programs as found in the Senate FY17 Commerce, Justice, Science, and Related Agencies Appropriations bill. Support HR 5963 Support strong, enforceable guidelines to ensure that School Resource Officers respect the civil rights of students. Support HR 6211 Support S. 2854 / H.R. 5067 Support S. 3144 / H.R. 5124 Support HR 4754 Support S.1513/H.R.3406 Oppose HR 3537

Client expense: $68,750 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Alcohol Tobacco Firearms & Explosives, Bureau of Prisons (BOP), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Council of Economic Advisers (CEA), Defense, Dept of (DOD), Education, Dept of, Election Assistance Commission (EAC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Housing Finance Agency (FHFA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Credit Union Administration (NCUA), Natl Institute of Standards & Technology (NIST), Natl Telecommunications & Information Administration (NTIA), Office of Faith-Based & Community Initiatives, Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

HR. 8 North American Energy Security and Infrastructure Act H.R. 1806 America COMPETES Act Reauthorization Act H.R. 3537 Synthetic Drug Control Act H.R. 4783 Commercializing on Small Business Innovation Act H.R. 4909 National Defense Authorization Act H.R. 5583 University Regulation Streamlining and Harmonization Act S. 3346 The NASA Transition Authorization Act S. 185 Promise for Antibiotics and Therapeutics for Health Act S. 771 Manufacturing Universities Act S. 2012 Energy Policy and Modernization Act S. 2089 American Energy Innovation Act S. 2658 Federal Aviation Administration (FAA) Modernization Act S. 2713 Advancing Precision Medicine Act of 2016 S. 2742 Promoting Biomedical Research and Public Health for Patients Act S. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act S. 2793 SBIR/STTR Reauthorization Act S. 2812 SBIR and STTR Reauthorization and Improvement Act S. 2898 Small Business National Security Innovation Act S. 2943 National Defense Authorization Act S. 3084, American Innovation and Competitiveness Act S. 3224 Synthetic Drug Control Act -- regarding research-related funding and policy issues affecting higher education institutions

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Substance Use Disorder (general); HIV Screening (general); Gynecologic Cancer (general); Gynecologic devices (general); Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); H.R.4695/S. 466, Quality Care for Moms and Babies Act; H.R. 3865/S.2542, Cradle Act;; H.R. 865/S. 3101, Good Samaritan Health Professionals Act; H.R. 4774, Training Tomorrows Doctors Today Act; H.R. 4771, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016; H.R. 1209/S.628 Improving Access to Maternity Care Act; Implementation of H.R. 1462/S. 799, Protecting our Infants Act; H.R. 3691/S. 2226, Improving Treatment for Pregnant and Postpartum Women Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 2972, Equal Access to Abortion Coverage in Health Insurance (EACH Woman) Act; H.Res. 461, Establishing a Select Investigative Panel of the Committee on Energy and Commerce; Fetal Tissue Research (General); H.R. 3706/S.1911, Reach Every Mother and Child Act of 2016; H.Res. 558/S.Res. 327, Condemning Violence That Targets Healthcare for Women; S. 304, Conscience Protection Act; H.R. 3504, Born-Alive Abortion Survivors Protection Act; Hyde Amendment (General); Senate Biomedical Innovations Packages (general); S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act; S.2742, Promoting Biomedical Research and Public Health for Patients Act; H.R. 6, 21st Century Cures Act; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3652/S. 674, 21st Century Womens Health Act; S. 1532, Affordability is Access Act; H.R. 5746, Birth Control Privacy Act; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3235/S. 2311, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); and H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act; H.R. 5369, Healthy Start Reauthorization Act; S. 3070, Hygiene Assistance for Families of Infants and Toddlers Act of 2016; H.R. 5219 Safe Medications for Moms and Babies Act of 2016; H.R. 953/S. 524, Comprehensive Addiction and Recovery Act; H.R. 2646, Helping Families in Mental Health Crisis Act; S. 2680, Mental Health Reform Act; H.R. 3537, Synthetic Drug Control Act; H.R. 4499/S. 2758, Promoting Responsible Opioid Prescribing (PROP) Act; H.R. 4874, Prevent Abuse by Using Interstate Exchange Act; H.R. 2805/S. 1134, Heroin and Prescription Opioid Abuse, Prevention, Education, and Enforcement Act; H.R. 2654/S. 1512, Pregnant Workers Fairness Act; H.R. 1706/S.2765, Real Education for Healthy Youth Act; H.R. 5065/ S. 3299 Bottles and Breastfeeding Equipment Screening Act; H.R. 6010, Zika Pregnancy and Infant Registry Act.

Client expense: $436,321 · Firm income: Not reported

Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, U.S. Agency for International Development (USAID), White House Office

H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment Biomedical innovation legislation (Senate draft) H.R.6, 21st Century Cures Act, Medical research issues. Drug abuse research and treatment related issues: H.R.3537, Synthetic Drug Control Act of 2015 H.R.2536/S.1455, Recovery Enhancement for Addiction Treatment Act TREAT Act Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016 S.2423/H.R.4447, Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act S.3224/H.R.5934, Dangerous Synthetic Drug Control Act of 2016 S.36/H.R.4229, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

S. 2123, Sentencing Reform and Corrections Act (bill to reduce certain mandatory minimum drug sentences); H.R. 3713, Sentencing Reform Act (bill to reduce certain mandatory minimum drug sentences); S. 3184/H.R. 5809, Back the Blue Act (bill to create mandatory minimums for certain offenses against law enforcement); S. 2193, Kate's Law (bill to create mandatory minimums for certain immigration offenses); H.R. 3537, Synthetic Drug Control Act of 2015 (bill to expand application of mandatory minimum drug sentences to synthetic substances); H.R. 759, Recidivism Risk Reduction Act (bill to create prison programming and credit system); consulted with White House to discuss/support clemency initiative

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3865-Cradle Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 S.36-Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.954-FDA Accountability for Public Safety Act S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1327-Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1654-Overdose Prevention Act S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2687-Plan of Safe Care Improvement Act

Client expense: $512,329 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.159-Stop Exploitation Through Trafficking Act H.R.181-Justice for Victims of Trafficking Act H.R.246-To improve the response to victims of child sex trafficking H.R.285-Stop Advertising Victims of Exploitation (SAVE) Act H.R.350-Human Trafficking Prevention, Intervention and Recovery Act H.R.357-Human Trafficking Prevention Act H.R.398-Trafficking Awareness Training for Health Care Act H.R.460-Human Trafficking Detection Act H.R.468-Enhancing Services for Runaway and Homeless Victims for Youth Trafficking Act H.R.469-Strengthening Child Welfare Response to Trafficking Act H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.514-Human Trafficking Prioritization Act H.R.515-International Megans Law to Prevent Demand for Child Sex H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 S.178-Justice for Victims of Trafficking Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.529-Combatting Human Trafficking Act of 2015 S.623-Human Trafficking Detection Act of 2015 S.642-Human Trafficking Survivors Relief and Empowerment Act of 2015 S.711-Mental Health First Act of 2015 S.993-Comprehensive Justice and Mental Health Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.2932-Protecting Patient Access to Emergency Medications Act of 2016

Client expense: $512,329 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.6-21st Century Cures Act H.R.33-Protecting Volunteer Firefighters and Emergency Responders Act H.R.290-Creating Access to Rehabilitation for Every Senior (CARES) Act of 2015 H.R.293-To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes. H.R.398-Trafficking Awareness Training for Health Care Act H.R.639-Improving Regulatory Transparency for New Medical Therapies Act H.R.647-Access to Life-Saving Trauma Care for All Americans Act H.R.648-Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R.836-Health Care Safety Net Enhancement Act H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1190-Protecting Seniors Access to Medicare Act of 2015 H.R.1571-Improving Access to Medicare Coverage Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1818-Veteran Emergency Medical Technician Support Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.2050-Middle Class Health Benefits Tax Repeal Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2366-Field EMS Modernization and Innovation Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2603-Saving Lives, Saving Costs Act H.R.2646-Helping Families in Mental Health Crisis Act of 2015 H.R.2799-Furthering Access to Stroke Telemedicine (FAST) Act H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.2948-Medicare Telehealth Parity Act of 2015 H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3299-Strengthening Public Health Emergency Response Act H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3681-Improving Access to Emergency Psychiatric Care Act H.R.3682-Reducing Employer Burdens, Unleashing Innovation, and Labor Development Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R.3770-End Surprise Billing Act of 2015 H.R.3865-Cradle Act H.R.4059-Medicare Choices Empowerment and Protection Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4150-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 H.R.4435-Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 H.R.4771-Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016 H.R.4732-Advancing Medical Resident Training in Community Hospitals Act of 2016 H.R.5243-Zika Response Appropriations Act H.R.5273-Helping Hospitals Improve Patient Care H.R.5284-World's Greatest Healthcare Plan Act of 2016 H.R.5547-Health Care Price Transparency Promotion Act of 2016 S.141-Protecting Seniors Access to Medicare Act of 2015 S.425-Homeless Veterans' Reintegration Programs Reauthorization Act of 2015 S.453-Veteran Emergency Medical Technician Support Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.599-Improving Access to Emergency Psychiatric Care Act S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.711-Mental Health First Act of 2015 S.763-Trauma Systems and Regionalization of Emergency Care Reauthorization Act S.884-Health Care Safety Net Enhancement Act S.843-Improving Access to Medicare Coverage Act of 2015 S.954-FDA Accountability for Public Safety Act S.993-Comprehensive Justice and Mental Health Act of 2015 S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.1450-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act S.1452-Veterans Emergency Health Safety Net Expansion Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1465-Furthering Access to Stroke Telemedicine (FAST) Act S.1475-Saving Lives, Saving Costs Act S.1549-Care Planning Act of 2015 S.1648-Rural Emergency Acute Care Hospital (REACH) Act S.1654-Overdose Prevention Act S.1693-To amend title 38, United States Code, to expand eligibility for reimbursement for emergency medical treatment to certain veterans that were unable to receive care from the Department of Veterans Affairs in the 24-month period preceding the furnishing of such emergency treatment, and for other purposes. S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015 S.1893-Mental Health Awareness and Improvement Act of 2015 S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.1945-Mental Health Reform Act of 2015 S.2002-Mental Health and Safe Communities Act of 2015 S.2045-Middle Class Health Benefits Tax Repeal Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2297-Medicare Choices Empowerment and Protection Act S.2525-Expand Excellence in Mental Health Act S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2597-Medicare Mental Health Access Act S.2671-Advancing Medical Resident Training in Community Hospitals Act of 2016 S.2680-Mental Health Reform Act of 2016 S.2687-Plan of Safe Care Improvement Act S.2932-Protecting Patient Access to Emergency Medications Act of 2016 S.2985-World's Greatest Healthcare Plan Act of 2016 P.L.114-10-Medicare Access and CHIP Reauthorization Act of 2015

Client expense: $512,329 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.46, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly cut States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 51, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 159/S. 166, the Stop Exploitation Through Trafficking Act, which would benefit law enforcement agencies in States with safe harbor laws when applying for Federal law enforcement grant programs; H.R. 181/S. 178, the Justice for Victims of Trafficking Act, would authorize grants be made available to law enforcement and others to develop, improve, or expand comprehensive domestic child trafficking deterrence; H.R. 228/S. 125, the Bulletproof Vest Partnership Grant Act, would reauthorize the Bulletproof Vest Partnership grant program through fiscal year 2018; H.R. 378, the Responsible Body Armor Possession Act, which would prohibit the sale, transfer, or possession of enhanced, military-grade body armor by civilians; H.R. 429, the Grand Jury Reform Act, would end the use of grand juries to evaluate the conduct of any death caused by a law enforcement officer acting in the performance of his sworn duty and require a special prosecutor to take the case before a judge; H.R. 723, the Fallen Heroes Flag Act, would provide that Members of the U.S. House of Representatives could request and then provide a flag be flown over the U.S. Capitol and then provide it to the family of a law enforcement or other public safety officer; H.R. 814, the Thin Blue Line Act, which increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 923/S. 498, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; H.R. 1186, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, which would close the existing loophole for the manufacturers on analogue drug sales and distribution; H.R. 1258, the "Pet and Women Safety (PAWS) Act," which would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program within the U.S. Department of Agriculture designed to assist victims of domestic violence to safely shelter their pets when they leave their abusers; H.R. 1269/S. 665, the Rafael Ramos and Wenjian Liu National Blue Alert Act, would create a national alert system for law enforcement officers who are missing, killed or seriously injured in the line of duty; Section 1042, H.R. 1735, the "National Defense Authorization Acy, Fiscal Year 2016;" H.R. 1786/S. 928, the James Zadroga 9/11 Health and Compensation Reauthorization Act, which would ensure continuation of the World Trade Center Health Program and the September 11th Victim Compensation Fund; H.R. 1933/S. 1056, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 2293, the "Preventing Animal Cruelty and Torture (PACT) Act," which would provide criminal penalties for those who engage in "animal crushing" as well as for those who create or distribute such films; H.R. 2318, the COPS Improvements and Reauthorization Act, would reauthorize, expand and improve the hiring program administered by the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice; H.R. 2330/S. 1119, the National Criminal Justice Commission Act, would create a National Criminal Justice Commission to study the nations criminal justice systems; H.R. 2667, the "School Safety Act," which would reauthorize and expand the Secure Our Schools program through 2020; H.R. 3036, the "National 9/11 Memorial at the World Trade Center Act," which would Federally recognize the 9/11 Memorial as a national memorial and authorize funding for its upkeep and preservation; H.R. 3537, the "Synthetic Drug Control Act," would enhance the ability fo law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 3968, the "Stop Meth Labs and Enhance Patient Access Act," which would encourage the use of new tamper-resistent technologies to prevent pseudoephedrine rom being extracted from cold medicines in order to be used in the production of methamphetamine; H.R. 4002, the "Criminal Code Improvement Act," which would would overturn long-standing court holdings on mens rea standards and applications and replace them with a new and arbitrary standard; Issues related to Federal equipment programs; and Issues related to Automated License Plate Reader (ALPR) technology, body worn cameras(BWCs), and civil asset forfeiture.

Client expense: $55,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), White House Office

H.R.3537, The Synthetic Drug Control Act H.R, 4229, The Protecting Our Youth from Dangerous Synthetic Drugs Act S. 36, Protecting Our Youth from Dangerous Synthetic Drugs Act

Client expense: $100,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3865-Cradle Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 S.36-Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.954-FDA Accountability for Public Safety Act S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1327-Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1654-Overdose Prevention Act S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2687-Plan of Safe Care Improvement Act

Client expense: $217,135 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.6-21st Century Cures Act H.R.33-Protecting Volunteer Firefighters and Emergency Responders Act H.R.290-Creating Access to Rehabilitation for Every Senior (CARES) Act of 2015 H.R.293-To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes. H.R.398-Trafficking Awareness Training for Health Care Act H.R.639-Improving Regulatory Transparency for New Medical Therapies Act H.R.647-Access to Life-Saving Trauma Care for All Americans Act H.R.648-Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R.836-Health Care Safety Net Enhancement Act H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1190-Protecting Seniors Access to Medicare Act of 2015 H.R.1571-Improving Access to Medicare Coverage Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1818-Veteran Emergency Medical Technician Support Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.2050-Middle Class Health Benefits Tax Repeal Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2366-Field EMS Modernization and Innovation Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2603-Saving Lives, Saving Costs Act H.R.2646-Helping Families in Mental Health Crisis Act of 2015 H.R.2799-Furthering Access to Stroke Telemedicine (FAST) Act H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.2948-Medicare Telehealth Parity Act of 2015 H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3299-Strengthening Public Health Emergency Response Act H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3681-Improving Access to Emergency Psychiatric Care Act H.R.3682-Reducing Employer Burdens, Unleashing Innovation, and Labor Development Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R.3770-End Surprise Billing Act of 2015 H.R.3865-Cradle Act H.R.4059-Medicare Choices Empowerment and Protection Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4150-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 H.R.4435-Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 H.R.4771-Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016 H.R.4732-Advancing Medical Resident Training in Community Hospitals Act of 2016 H.R.5243-Zika Response Appropriations Act H.R.5273-Helping Hospitals Improve Patient Care H.R.5284-World's Greatest Healthcare Plan Act of 2016 H.R.5547-Health Care Price Transparency Promotion Act of 2016 S.141-Protecting Seniors Access to Medicare Act of 2015 S.425-Homeless Veterans' Reintegration Programs Reauthorization Act of 2015 S.453-Veteran Emergency Medical Technician Support Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.599-Improving Access to Emergency Psychiatric Care Act S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.711-Mental Health First Act of 2015 S.763-Trauma Systems and Regionalization of Emergency Care Reauthorization Act S.884-Health Care Safety Net Enhancement Act S.843-Improving Access to Medicare Coverage Act of 2015 S.954-FDA Accountability for Public Safety Act S.993-Comprehensive Justice and Mental Health Act of 2015 S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.1450-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act S.1452-Veterans Emergency Health Safety Net Expansion Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1465-Furthering Access to Stroke Telemedicine (FAST) Act S.1475-Saving Lives, Saving Costs Act S.1549-Care Planning Act of 2015 S.1648-Rural Emergency Acute Care Hospital (REACH) Act S.1654-Overdose Prevention Act S.1693-To amend title 38, United States Code, to expand eligibility for reimbursement for emergency medical treatment to certain veterans that were unable to receive care from the Department of Veterans Affairs in the 24-month period preceding the furnishing of such emergency treatment, and for other purposes. S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015 S.1893-Mental Health Awareness and Improvement Act of 2015 S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.1945-Mental Health Reform Act of 2015 S.2002-Mental Health and Safe Communities Act of 2015 S.2045-Middle Class Health Benefits Tax Repeal Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2297-Medicare Choices Empowerment and Protection Act S.2525-Expand Excellence in Mental Health Act S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2597-Medicare Mental Health Access Act S.2671-Advancing Medical Resident Training in Community Hospitals Act of 2016 S.2680-Mental Health Reform Act of 2016 S.2687-Plan of Safe Care Improvement Act S.2932-Protecting Patient Access to Emergency Medications Act of 2016 S.2985-World's Greatest Healthcare Plan Act of 2016

Client expense: $217,135 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.159-Stop Exploitation Through Trafficking Act H.R.181-Justice for Victims of Trafficking Act H.R.246-To improve the response to victims of child sex trafficking H.R.285-Stop Advertising Victims of Exploitation (SAVE) Act H.R.350-Human Trafficking Prevention, Intervention and Recovery Act H.R.357-Human Trafficking Prevention Act H.R.398-Trafficking Awareness Training for Health Care Act H.R.460-Human Trafficking Detection Act H.R.468-Enhancing Services for Runaway and Homeless Victims for Youth Trafficking Act H.R.469-Strengthening Child Welfare Response to Trafficking Act H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.514-Human Trafficking Prioritization Act H.R.515-International Megans Law to Prevent Demand for Child Sex H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 S.178-Justice for Victims of Trafficking Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.529-Combatting Human Trafficking Act of 2015 S.623-Human Trafficking Detection Act of 2015 S.642-Human Trafficking Survivors Relief and Empowerment Act of 2015 S.711-Mental Health First Act of 2015 S.993-Comprehensive Justice and Mental Health Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.2932-Protecting Patient Access to Emergency Medications Act of 2016

Client expense: $217,135 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Drug Dependence (general); HIV Screening (general); Gynecologic Cancer (general); Gynecologic devices (general); Breast Cancer (general); Breastfeeding (general); Medical Liability Reform (general); Health IT (general); Prematurity (general); Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); Meaningful Use Stage 3; H.R. 3940, Meaningful Use Hardship Relief Act; H.R.4695/S. 466, Quality Care for Moms and Babies Act; H.R. 3865/S.2542, Cradle Act; H.R. 836/S. 884, Health Care Safety Net Enhancement Act; H.R. 865, Good Samaritan Health Professionals Act; H.R. 2603/S. 1475, Saving Lives, Saving Costs Act; H.R. 4774, Training Tomorrows Doctors Today Act; H.R. 3658/S. 84, GEDI Act; H.R. 4771, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016; H.R. 1209/S.628 Improving Access to Maternity Care Act; Implementation of H.R. 1462/S. 799, Protecting our Infants Act; H.R. 3691/S. 2226, Improving Treatment for Pregnant and Postpartum Women Act; H.R. 448/S.217, Women's Health Protection Act of 2015; H.R. 2972, Equal Access to Abortion Coverage in Health Insurance (EACH Woman) Act; H.Res. 461, Establishing a Select Investigative Panel of the Committee on Energy and Commerce; Fetal Tissue Research (General); H.R. 3706/S.1911, Reach Every Mother and Child Act of 2016; H.Res. 558/S.Res. 327, Condemning Violence That Targets Healthcare for Women; H.R. 4924/S.48, Prenatal Nondiscrimination Act (PRENDA) of 2016; Senate Biomedical Innovations Packages (general); S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act; S.2742, Promoting Biomedical Research and Public Health for Patients Act; H.R. 3656/S. 2100, Tobacco to 21 Act; H.R. 3652/S. 674, 21st Century Womens Health Act; S. 1532, Affordability is Access Act; H.R. 2058, FDA Deeming Authority Clarification Act of 2015; H.R. 3441, Accurate Education for Prenatal Screenings Act; H.R. 3235/S. 2311, Bringing Postpartum Depression Out of the Shadows Act; Shackling During Pregnancy (general); and H.R. 3539, Reinvigorating Antibiotic and Diagnostic Innovation Act; H.R. 5369, Healthy Start Reauthorization Act; S. 3070, Hygiene Assistance for Families of Infants and Toddlers Act of 2016; H.R. 5219 Safe Medications for Moms and Babies Act of 2016; H.R. 953/S. 524, Comprehensive Addiction and Recovery Act; H.R. 2646, Helping Families in Mental Health Crisis Act; S. 2680, Mental Health Reform Act; H.R. 3537, Synthetic Drug Control Act; H.R. 4499/S. 2758, Promoting Responsible Opioid Prescribing (PROP) Act; H.R. 4874, Prevent Abuse by Using Interstate Exchange Act; H.R. 2805/S. 1134, Heroin and Prescription Opioid Abuse, Prevention, Education, and Enforcement Act; H.R. 2654/S. 1512, Pregnant Workers Fairness Act; H.R. 1706/S.2765, Real Education for Healthy Youth Act.

Client expense: $486,704 · Firm income: Not reported

Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment H.R.6, 21st Century Cures Act, Medical research issues. Drug abuse research and treatment related issues: S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 1622, The FDA Device Accountability Act of 2015 S. 2014, Next Generation Researchers Act S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act S. 849, Advancing Research for Neurological Diseases Act of 2015 S. 2503, Preventing Superbugs and Protecting Patients Act S. 2511, Improving Health Information Technology S. 1878, The Advancing Hope Act of 2015 S. 1077, The Advancing Breakthrough Medical Devices for Patients Act of 2015 S. 1101, The Medical Electronic Data Technology Enhancement for Consumers Health Act S. 2055, The Medical Countermeasures Innovation Act of 2015 S. 1767, The Combination Products Innovation Act of 2015 S. 1597, Patient Focused Impact Assessment Act of 2015 S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act S. 2700, FDA and NIH Workforce Authorities Modernization Act S. 185, Promise for Antibiotics and Therapeutics for Health Act S. 2713, Advancing Precision Medicine Act of 2016 S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act S. 2742, Promoting Biomedical Research and Public Health for Patients Act Opioid abuse legislation. H.R.2872, Opioid Addiction Treatment Modernization Act H.R.3537, Synthetic Drug Control Act of 2015 H.R.2536/S.1455, Recovery Enhancement for Addiction Treatment Act TREAT Act H.R.2805, Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.3014, Medical Controlled Substances Transportation Act of 2015 H.R.3716, Ensuring Terminated Providers are Removed from Medicaid and CHIP Act H.R.3821, Medicaid DOC Act H.R.2646, Helping Families in Mental Health Crisis Act of 2015 S.524, Comprehensive Addiction and Recovery Act of 2016 H.R.4396, Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2256, Co-Prescribing Saves Lives Act of 2015 S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.2680, Mental Health Reform Act of 2016 S.2687, Plan of Safe Care Improvement Act S.2423/H.R.4447, Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act S.1455/H.R.2536, Recovery Enhancement for Addiction Treatment Act (TREAT Act) H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016 H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016 H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016 H.R.4586, Lali's Law H.R.4976, Opioid Review Modernization Act of 2016 H.R.4599, Reducing Unused Medications Act of 2016 H.R.4969, John Thomas Decker Act of 2016 H.R.4641, To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4978, NAS Healthy Babies Act H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016 H.R.4229/S.36, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

HR. 8 North American Energy Security and Infrastructure Act H.R. 1806 America COMPETES Act Reauthorization Act H.R. 3293 Science in the National Interest H.R. 3537 Synthetic Drug Control Act S. 185 Promise for Antibiotics and Therapeutics for Health Act S. 2012 Energy Policy and Modernization Act S. 2089 American Energy Innovation Act S. 2658 Federal Aviation Administration (FAA) Modernization Act S. 2700 FDA and NIH Workforce Authorities Modernization Act S. 2713 Advancing Precision Medicine Act of 2016 S. 2742 Promoting Biomedical Research and Public Health for Patients Act S. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act S. 2793 SBIR/STTR Reauthorization Act S. 2812 SBIR and STTR Reauthorization and Improvement Act S. 2898 Small Business National Security Innovation Act Senate COMPETES Act Reauthorization Act University Regulation Streamlining and Harmonization Act -- regarding research-related funding and policy issues affecting higher education institutions

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to NIH funding S. 320: Medical Innovation Act of 2015 - Provisions related to National Institutes of Health (NIH) funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2016 - Provisions related to registration under the Controlled Substances Act (CSA) S. 524: Comprehensive Addiction and Recovery Act of 2016 - Provisions related to opioids S. 683: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 849: Advancing Research for Neurological Diseases Act of 2016 - Provisions related to research on neurological diseases S. 1128: Preserving Access to Orphan Drugs Act - Provisions related to orphan drug tax (113th Congress) S. 1455: Recovery Enhancement for Addiction Treatment Act - Provisions related to opioids S. 1597: Patient-Focused Impact Assessment Act of 2016 - Provisions related to patient-focused drug development S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2016 - Provisions related to improvements in the regulation of combination drug-device products S. 1878: Advancing Hope Act of 2016 - Provisions related to pediatric cancer and other pediatric diseases S. 2014: Next Generation Researchers Act - Provisions related to NIH promoting new research. S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016 - Provisions related to rare disease treatment S. 2055 - the Medical Countermeasure Innovation Act of 2015 S. 2256: Co-Prescribing Saves Lives Act of 2015 - Provisions related to co-prescribing S. 2388: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 - Provisions related to reciprocity of drug approvals S. 2503: Preventing Superbugs and Protecting Patients Act - Provisions related to antibiotic development S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act - Provisions related to priority review vouchers S. 2615: Increasing Competition in Pharmaceuticals Act - Provisions related to FDA review of generic drugs and study on risk evaluation and mitigation strategies (REMS) program S. 2624: National Biomedical Research Act - Provisions related to mandatory funding for NIH and FDA S. 2680: Mental Health Reform Act of 2016 - Provisions related to mental health issues S. 2689: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments S. 2700: FDA and NIH Workforce Modernization Act - Provisions related to FDA and NIH H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2745: Standard Merger and Acquisition Reviews Through Equal Rules Act of 2015; Motion to Recommit H.R. 2745 with Instructions - Provisions related to prescription drug costs H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing HR. 3299 - the Strengthening Public Health Emergency Response Act of 2015 H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3762: Restoring Americans Healthcare Freedom Reconciliation Act of 2015 - Provisions related to amending and withdrawing funding from the Affordable Care Act H.R. 4365: Protecting Patient Access to Emergency Medications Act of 2016 - Provisions related to controlled substances H.R. 4762: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments H.R. 4784: Lower Drug Costs Through Competition Act - Provisions related to generic drugs and priority review vouchers; REMS study; and tropical disease product applications The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act policy issues Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed rules [CMS-2390-P] Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy including sharing of truthful and non-misleading information about medicines with healthcare professionals Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biologics Price Competition and Innovation Act (BPCIA) implementation issues Generic Drug User Fee Act (GDUFA) policy issues Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Expedited drug approval policy issues Compassionate use policy issues Biosimilar approval and reimbursement policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker policy issues Policy issues related to prescription drug abuse and secure disposal Antibiotics development policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner Prescription drug importation policy issues Cancer Moonshot

Client expense: $1,490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), Vice President of the U.S.

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to NIH funding S. 320: Medical Innovation Act of 2015 - Provisions related to National Institutes of Health (NIH) funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2016 - Provisions related to registration under the Controlled Substances Act (CSA) S. 524: Comprehensive Addiction and Recovery Act of 2016 - Provisions related to opioids S. 683: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 849: Advancing Research for Neurological Diseases Act of 2016 - Provisions related to research on neurological diseases S. 1128: Preserving Access to Orphan Drugs Act of 2013 - Provisions related to orphan drug tax (113th Congress) S. 1455: Recovery Enhancement for Addiction Treatment Act - Provisions related to opioids S. 1597: Patient-Focused Impact Assessment Act of 2016 - Provisions related to patient-focused drug development S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2016 - Provisions related to improvements in the regulation of combination drug-device products S. 1878: Advancing Hope Act of 2016 - Provisions related to pediatric cancer and other pediatric diseases S. 2014: Next Generation Researchers Act - Provisions related to NIH promoting new research. S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016 - Provisions related to rare disease treatment S. 2256: Co-Prescribing Saves Lives Act of 2015 - Provisions related to co-prescribing of opioids and reversal agents S. 2388: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 - Provisions related to reciprocity of drug approvals S. 2503: Preventing Superbugs and Protecting Patients Act - Provisions related to antibiotic development S. 2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act - Provisions related to priority review vouchers S. 2615: Increasing Competition in Pharmaceuticals Act - Provisions related to FDA review of generic drugs and study on risk evaluation and mitigation strategies (REMS) program S. 2624: National Biomedical Research Act - Provisions related to mandatory funding for NIH and FDA S. 2680: Mental Health Reform Act of 2016 - Provisions related to mental health issues S. 2689: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments S. 2700: FDA and NIH Workforce Modernization Act - Provisions related to FDA and NIH H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2745: Standard Merger and Acquisition Reviews Through Equal Rules Act of 2015; Motion to Recommit H.R. 2745 with Instructions - Provisions related to prescription drug costs H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3762: Restoring Americans Healthcare Freedom Reconciliation Act of 2015 - Provisions related to amending and withdrawing funding from the Affordable Care Act H.R. 4365: Protecting Patient Access to Emergency Medications Act of 2016 - Provisions related to controlled substances H.R. 4762: REGROW Act - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments H.R. 4784: Lower Drug Costs Through Competition Act - Provisions related to generic drugs and priority review vouchers; REMS study; and tropical disease product applications The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act policy issues Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed rules [CMS-2390-P] Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy including sharing of truthful and non-misleading information about medicines with healthcare professionals Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biologics Price Competition and Innovation Act (BPCIA) implementation issues Generic Drug User Fee Act (GDUFA) policy issues Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Expedited drug approval policy issues Compassionate use policy issues Biosimilar approval and reimbursement policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker policy issues Policy issues related to prescription drug abuse and secure disposal Antibiotics development policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner Prescription drug importation policy issues Cancer Moonshot

Client expense: $5,950,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), Vice President of the U.S.

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment H.R.6, 21st Century Cures Act, Medical research issues. Drug abuse research and treatment related issues: S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 1622, The FDA Device Accountability Act of 2015 S. 2014, Next Generation Researchers Act S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act S. 849, Advancing Research for Neurological Diseases Act of 2015 S. 2503, Preventing Superbugs and Protecting Patients Act S. 2511, Improving Health Information Technology S. 1878, The Advancing Hope Act of 2015 S. 1077, The Advancing Breakthrough Medical Devices for Patients Act of 2015 S. 1101, The Medical Electronic Data Technology Enhancement for Consumers Health Act S. 2055, The Medical Countermeasures Innovation Act of 2015 S. 1767, The Combination Products Innovation Act of 2015 S. 1597, Patient Focused Impact Assessment Act of 2015 S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act S. 2700, FDA and NIH Workforce Authorities Modernization Act S. 185, Promise for Antibiotics and Therapeutics for Health Act S. 2713, Advancing Precision Medicine Act of 2016 S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act S. 2742, Promoting Biomedical Research and Public Health for Patients Act Opioid abuse legislation. H.R.2872, Opioid Addiction Treatment Modernization Act H.R.3537, Synthetic Drug Control Act of 2015 H.R.2536/S.1455, Recovery Enhancement for Addiction Treatment Act TREAT Act H.R.2805, Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.3014, Medical Controlled Substances Transportation Act of 2015 H.R.3716, Ensuring Terminated Providers are Removed from Medicaid and CHIP Act H.R.3821, Medicaid DOC Act H.R.2646, Helping Families in Mental Health Crisis Act of 2015 S.524, Comprehensive Addiction and Recovery Act of 2016 H.R.4396, Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2256, Co-Prescribing Saves Lives Act of 2015 S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.2680, Mental Health Reform Act of 2016 S.2687, Plan of Safe Care Improvement Act S.2423/H.R.4447, Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3865-Cradle Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 S.36-Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.954-FDA Accountability for Public Safety Act S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1327-Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1654-Overdose Prevention Act S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2687-Plan of Safe Care Improvement Act

Client expense: $661,366 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.159-Stop Exploitation Through Trafficking Act H.R.181-Justice for Victims of Trafficking Act H.R.246-To improve the response to victims of child sex trafficking H.R.285-Stop Advertising Victims of Exploitation (SAVE) Act H.R.350-Human Trafficking Prevention, Intervention and Recovery Act H.R.357-Human Trafficking Prevention Act H.R.398-Trafficking Awareness Training for Health Care Act H.R.460-Human Trafficking Detection Act H.R.468-Enhancing Services for Runaway and Homeless Victims for Youth Trafficking Act H.R.469-Strengthening Child Welfare Response to Trafficking Act H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.514-Human Trafficking Prioritization Act H.R.515-International Megans Law to Prevent Demand for Child Sex H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 S.178-Justice for Victims of Trafficking Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.529-Combatting Human Trafficking Act of 2015 S.623-Human Trafficking Detection Act of 2015 S.642-Human Trafficking Survivors Relief and Empowerment Act of 2015 S.711-Mental Health First Act of 2015 S.993-Comprehensive Justice and Mental Health Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015

Client expense: $661,366 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.6-21st Century Cures Act H.R.33-Protecting Volunteer Firefighters and Emergency Responders Act H.R.290-Creating Access to Rehabilitation for Every Senior (CARES) Act of 2015 H.R.293-To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes. H.R.398-Trafficking Awareness Training for Health Care Act H.R.639-Improving Regulatory Transparency for New Medical Therapies Act H.R.647-Access to Life-Saving Trauma Care for All Americans Act H.R.648-Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R.836-Health Care Safety Net Enhancement Act H.R.953-Comprehensive Addiction and Recovery Act of 2015 H.R.1190-Protecting Seniors Access to Medicare Act of 2015 H.R.1571-Improving Access to Medicare Coverage Act of 2015 H.R.1641-Jason Simcakoski Memorial Opioid Safety Act H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1818-Veteran Emergency Medical Technician Support Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.2050-Middle Class Health Benefits Tax Repeal Act of 2015 H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act H.R.2366-Field EMS Modernization and Innovation Act H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015 H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act H.R.2603-Saving Lives, Saving Costs Act H.R.2646-Helping Families in Mental Health Crisis Act of 2015 H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.2872-Opioid Addiction Treatment Modernization Act H.R.3014-Medical Controlled Substances Transportation Act of 2015 H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015 H.R.3250-DXM Abuse Prevention Act of 2015 H.R.3379-Airplane Kids In Transit Safety (KITS) Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015 H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015 H.R.3681-Improving Access to Emergency Psychiatric Care Act H.R.3682-Reducing Employer Burdens, Unleashing Innovation, and Labor Development Act of 2015 H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015 H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R.3770-End Surprise Billing Act of 2015 H.R.3865-Cradle Act H.R.4059-Medicare Choices Empowerment and Protection Act H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act H.R.4150-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016 H.R.4435-Comprehensive Behavioral Health Reform and Recovery Act of 2016 H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016 H.R.4599-Reducing Unused Medications Act of 2016 H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. H.R.4697-Prevevent Drug Addiction Act of 2016 H.R.4771-Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016 S.141-Protecting Seniors Access to Medicare Act of 2015 S.425-Homeless Veterans' Reintegration Programs Reauthorization Act of 2015 S.453-Veteran Emergency Medical Technician Support Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.524-Comprehensive Addiction and Recovery Act of 2015 S.599-Improving Access to Emergency Psychiatric Care Act S.636-Increasing the Safety of Prescription Drug Use Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.711-Mental Health First Act of 2015 S.763-Trauma Systems and Regionalization of Emergency Care Reauthorization Act S.884-Health Care Safety Net Enhancement Act S.843-Improving Access to Medicare Coverage Act of 2015 S.954-FDA Accountability for Public Safety Act S.993-Comprehensive Justice and Mental Health Act of 2015 S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 S.1392-Safer Prescribing of Controlled Substances Act S.1410-Treatment and Recovery Investment Act S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.1450-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act S.1452-Veterans Emergency Health Safety Net Expansion Act of 2015 S.1455-Recovery Enhancement for Addiction Treatment Act S.1475-Saving Lives, Saving Costs Act S.1549-Care Planning Act of 2015 S.1648-Rural Emergency Acute Care Hospital (REACH) Act S.1654-Overdose Prevention Act S.1693-To amend title 38, United States Code, to expand eligibility for reimbursement for emergency medical treatment to certain veterans that were unable to receive care from the Department of Veterans Affairs in the 24-month period preceding the furnishing of such emergency treatment, and for other purposes. S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015 S.1893-Mental Health Awareness and Improvement Act of 2015 S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015 S.1945-Mental Health Reform Act of 2015 S.2002-Mental Health and Safe Communities Act of 2015 S.2045-Middle Class Health Benefits Tax Repeal Act of 2015 S.2256-Co-Prescribing Saves Lives Act of 2015 S.2297-Medicare Choices Empowerment and Protection Act S.2525-Expand Excellence in Mental Health Act S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act S.2567-Preventing Overprescribing for Pain Act of 2016 S.2578-Reducing Unused Medications Act of 2016 S.2597-Medicare Mental Health Access Act S.2680-Mental Health Reform Act of 2016 S.2687-Plan of Safe Care Improvement Act

Client expense: $661,366 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3537, Synthetic Drug Control Act of 2015, all provisions H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions H.R. 1270, Restoring Access to Medication Act of 2015, all provisions S. 709, Restoring Access to Medication Act of 2015, all provisions H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R. 3309, Flex-IT 2 Act, all provisions S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions H.R. 3520, Pulmonary Hypertension Research and Diagnosis Act of 2015, all provisions H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions S. 1945, Mental Health Reform Act of 2015, all provisions H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions H.R.6, 21st Century Cures Act, all provisions H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2015, all provisions H.R. 3770, End Surprise Billing Act of 2015, all provisions Radiation Oncology Therapy Coding Medical Licensure - The Interstate Medical Licensure Compact Prescription Drug Diversion and Abuse Physician Owned Hospitals Health Savings Accounts - Prescription requirements for over-the-counter medications Opioid Abuse Telemedicine Drug Pricing Electronic Health Records (EHR) interoperability and certification Meaningful Use/hardship exemptions and Stage 3 regulations Precision Medicine Cybersecurity Sunshine Act FDA/NIH Modernization Laboratory Developed Tests (LDT) Mental health and HIPAA privacy law HIPAA Chronic care Child-resistant packaging for energy drinks COBRA grace period Dietary guidelines ICD-10 Antibiotic resistance Pre-diabetes Hypertension Homelessness - impact on health XR-29-2013 related penalty/12 month delay Clinical Laboratory Improvement Amendments (CLIA)/oversight modernization

Client expense: $4,530,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.46, the No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act, which would significantly cut States who fund anti-drug task forces from receiving Federal funding from the Edward J. Byrne Memorial Justice Assistant Grants program; H.R. 51, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 159/S. 166, the Stop Exploitation Through Trafficking Act, which would benefit law enforcement agencies in States with safe harbor laws when applying for Federal law enforcement grant programs; H.R. 181/S. 178, the Justice for Victims of Trafficking Act, would authorize grants be made available to law enforcement and others to develop, improve, or expand comprehensive domestic child trafficking deterrence; H.R. 228/S. 125, the Bulletproof Vest Partnership Grant Act, would reauthorize the Bulletproof Vest Partnership grant program through fiscal year 2018; H.R. 378, the Responsible Body Armor Possession Act, which would prohibit the sale, transfer, or possession of enhanced, military-grade body armor by civilians; H.R. 429, the Grand Jury Reform Act, would end the use of grand juries to evaluate the conduct of any death caused by a law enforcement officer acting in the performance of his sworn duty and require a special prosecutor to take the case before a judge; H.R. 723, the Fallen Heroes Flag Act, would provide that Members of the U.S. House of Representatives could request and then provide a flag be flown over the U.S. Capitol and then provide it to the family of a law enforcement or other public safety officer; H.R. 814, the Thin Blue Line Act, which increase the penalty for offenders who kill or attempt to kill law enforcement or other public safety officers; H.R. 923/S. 498, the Constitutional Concealed Carry Reciprocity Act, which would allow any civilian concealed carry permit holder to travel to any other State issuing concealed carry permits without any training or safety requirements; H.R. 1186, the Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, which would close the existing loophole for the manufacturers on analogue drug sales and distribution; H.R. 1258, the "Pet and Women Safety (PAWS) Act," which would expand existing Federal protections to the pets of domestic abuse victims and establish a grant program within the U.S. Department of Agriculture designed to assist victims of domestic violence to safely shelter their pets when they leave their abusers; H.R. 1269/S. 665, the Rafael Ramos and Wenjian Liu National Blue Alert Act, would create a national alert system for law enforcement officers who are missing, killed or seriously injured in the line of duty; Section 1042, H.R. 1735, the "National Defense Authorization Acy, Fiscal Year 2016;" H.R. 1786/S. 928, the James Zadroga 9/11 Health and Compensation Reauthorization Act, which would ensure continuation of the World Trade Center Health Program and the September 11th Victim Compensation Fund; H.R. 1933/S. 1056, the End Racial Profiling Act, which would define racial profiling as any consideration of race, national origin or ethnic origin to initiate a traffic stop or vehicle search-absent an eyewitness description-and requires the collection of race and other data by State and local law enforcement during routine investigatory activities; H.R. 2293, the "Preventing Animal Cruelty and Torture (PACT) Act," which would provide criminal penalties for those who engage in "animal crushing" as well as for those who create or distribute such films; H.R. 2318, the COPS Improvements and Reauthorization Act, would reauthorize, expand and improve the hiring program administered by the Office of Community Oriented Policing Services (COPS) within the U.S. Department of Justice; H.R. 2330/S. 1119, the National Criminal Justice Commission Act, would create a National Criminal Justice Commission to study the nations criminal justice systems; H.R. 2667, the "School Safety Act," which would reauthorize and expand the Secure Our Schools program through 2020; H.R. 3036, the "National 9/11 Memorial at the World Trade Center Act," which would Federally recognize the 9/11 Memorial as a national memorial and authorize funding for its upkeep and preservation; H.R. 3537, the "Synthetic Drug Control Act," would enhance the ability fo law enforcement to combat synthesized drugs by amending the Controlled Substances Act to clarify how controlled substance analogues are to be regulated; H.R. 3968, the "Stop Meth Labs and Enhance Patient Access Act," which would encourage the use of new tamper-resistent technologies to prevent pseudoephedrine rom being extracted from cold medicines in order to be used in the production of methamphetamine; H.R. 4002, the "Criminal Code Improvement Act," which would would overturn long-standing court holdings on mens rea standards and applications and replace them with a new and arbitrary standard; Issues related to Federal equipment programs; and Issues related to Automated License Plate Reader (ALPR) technology, body worn cameras(BWCs), and civil asset forfeiture.

Client expense: $55,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), White House Office

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to NIH funding S. 320: Medical Innovation Act of 2015 - Provisions related to National Institutes of Health (NIH) funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the Controlled Substances Act (CSA) S. 683: Compassionate Access, Research Expansion, and Respect States Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 1128: Preserving Access to Orphan Drugs Act - Provisions related to orphan drug tax (113th Congress) S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: The Combination Product Regulatory Fairness Act of 2015 - Provisions related to improvements in the regulation of combination drug-device products S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation S. 2055 - the Medical Countermeasure Innovation Act of 2015 H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 471: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the CSA H.R. 639: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to DEA scheduling H.R. 880: American Research and Competitiveness Act of 2015 - Provisions related to the research and development (R&D) tax credit H.R. 909: Andrea Sloan Compassionate Use Reform and Enhancement Act - Provisions related to expanded access H.R. 1321: Microbead-Free Waters Act of 2015 - Provisions related to bills applicability to prescription drugs H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 1635: Charlottes Web Medical Access Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review - Provisions regarding the enhancement of combination products review H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2536: Recovery Enhancement for Addiction Treatment Act - Provisions related to the treatment of drug addiction H.R. 2629: Antibiotic Development to Advance Patient Treatment Act - Provisions related to the approval of certain drugs for use in a limited population of patients H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015 - Provisions related to the reauthorization of the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 2872: Opioid Addiction Treatment Modernization Act - Provisions related to the treatment of opioid addiction H.R. 3014: Medical Controlled Substances Transportation Act of 2015 - Provisions related to the transport of controlled substances by physicians in certain situations HR. 3299 - the Strengthening Public Health Emergency Response Act of 2015 H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3680: Co-Prescribing to Reduce Overdoses Act of 2015 - Provisions related to the prescribing of opioid overdose reversal drug to at-risk patients H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act - Provisions related to amending and withdrawing funding from the Affordable Care Act The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act issues including the Charitable Donation Exemption Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed Rules [CMS-2390-P] Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker proposed legislation - Draft legislation related to developing a new approval pathway for biomarkers Rogue Internet Pharmacy policy issues Prescription drug abuse policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner

Client expense: $380,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

H.R. 3466/S. 2014, the Next Generation Researchers Act - provisions related to supporting early career investigators and faster roads to research independence H.R. 2029, the Omnibus Appropriations and Tax Extenders Act - provisions related to funding for research agencies including HHS, NIH H.R. 6, the 21st Century Cures Act - provisions related to the Innovation Fund for NIH, streamlining clinical trials, reducing research administrative burden, and NCATS. S. xxx, the Innovations for Healthier Americans bill - provisions related to NIH funding, regulatory reform, laboratory developed tests, and other policy provisions H.R. 3537, the Synthetic Drug Act - provisions related to restrictions of synthetic drug compounds as they pertain to use by researchers General issues related to the NPRM on the Common Rule Issues related to biomedical research funding, particularly at NIH General issues related to the Precision Medicine Initiative

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6: 21st Century Cures Act. H.R. 3537: Synthetic Drug Control Act of 2015. H.R. 1786: "James Zadroga 9/11 Health and Compensation Reauthorization Act" with respect to potential budgetary offsets.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3537, Synthetic Drug Control Act of 2015, all provisions H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions H.R. 1270, Restoring Access to Medication Act of 2015, all provisions S. 709, Restoring Access to Medication Act of 2015, all provisions H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R. 3309, Flex-IT 2 Act, all provisions S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions H.R. 3520, Pulmonary Hypertension Research and Diagnosis Act of 2015, all provisions H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions S. 1945, Mental Health Reform Act of 2015, all provisions H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions H.R.6, 21st Century Cures Act, all provisions H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2015, all provisions H.R. 3770, End Surprise Billing Act of 2015, all provisions Radiation Oncology Therapy Coding Medical Licensure - The Interstate Medical Licensure Compact Prescription Drug Diversion and Abuse Physician Owned Hospitals Health Savings Accounts - Prescription requirements for over-the-counter medications Opioid Abuse Telemedicine Drug Pricing Electronic Health Records (EHR) interoperability and certification Meaningful Use/hardship exemptions and Stage 3 regulations Precision Medicine Cybersecurity Sunshine Act FDA/NIH Modernization Laboratory Developed Tests (LDT) Mental health and HIPAA privacy law HIPAA Chronic care Child-resistant packaging for energy drinks COBRA grace period Dietary guidelines ICD-10 Antibiotic resistance Pre-diabetes Hypertension Homelessness - impact on health XR-29-2013 related penalty/12 month delay Clinical Laboratory Improvement Amendments (CLIA)/oversight modernization

Client expense: $4,490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

S. 122: Safe and Affordable Drugs from Canada Act of 2015 - Provisions related to importation S. 185: Promise for Antibiotics and Therapeutics for Health (PATH) Act - Provisions related to antibiotic drug approval for a limited population S. 289: American Cures Act - Provisions related to National Institutes of Health (NIH) funding S. 320: Medical Innovation Act of 2015 - Provisions related to NIH funding and covered manufacturer supplemental fees S. 481: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to Drug Enforcement Administration (DEA) scheduling S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the Controlled Substances Act (CSA) S. 683: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research S. 1128: Preserving Access to Orphan Drugs Act - Provisions related to orphan drug tax (113th Congress) S. 1790: Safe and Affordable Prescription Drugs Act of 2015 - Provisions related to importation S. 1767: Combination Product Regulatory Fairness Act of 2015 - Provisions related to improvements in the regulation of combination drug-device products S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to importation H.R. 6: 21st Century Cures Act - Provisions related to biopharmaceutical discovery, development, delivery and transparency H.R. 471: Ensuring Patient Access and Effective Drug Enforcement Act of 2015 - Provisions related to registration under the CSA H.R. 639: Improving Regulatory Transparency for New Medical Therapies Act - Provisions related to DEA scheduling H.R. 880: American Research and Competitiveness Act of 2015 - Provisions related to the research and development (R&D) tax credit H.R. 909: Andrea Sloan Compassionate Use Reform and Enhancement Act - Provisions related to expanded access H.R. 1321: Microbead-Free Waters Act of 2015 - Provisions related to bills applicability to prescription drugs H.R. 1455: Speeding Access to Already Approved Pharmaceuticals Act of 2015 - Provisions requiring FDA to expedite review of pharmaceuticals that are approved for marketing in the European Union H.R. 1537: Advancing Hope Act of 2015 - Provisions related to the pediatric rare disease voucher program H.R. 1538: Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 1576: Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015 - Provisions related to the study of regulatory challenges for the approval of complex generic drugs H.R. 1635: Charlottes Web Medical Access Act of 2015 - Provisions related to regulation of marijuana and impact on legitimate medical research H.R. 2433: To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review - Provisions regarding the enhancement of combination products review H.R. 2479: To amend the Federal Food, Drug, and Cosmetic Act to provide for the issuance of up-to-date regulations and guidance applying to the dissemination by means of the Internet of information about medical products - Provisions related to dissemination of information about medical products H.R. 2536: Recovery Enhancement for Addiction Treatment Act - Provisions related to the treatment of drug addiction H.R. 2629: Antibiotic Development to Advance Patient Treatment Act - Provisions related to the approval of certain drugs for use in a limited population of patients H.R. 2805: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 - Provisions related to the treatment of heroin and prescription opioid abuse H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015 - Provisions related to the reauthorization of the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program H.R. 2841: Fair Access for Safe and Timely Generics Act of 2015 - Provisions related to requiring innovator pharmaceutical manufacturers to provide samples of risk evaluation and mitigation strategy (REMS) covered products to generic manufacturers for bioequivalence testing H.R. 2872: Opioid Addiction Treatment Modernization Act - Provisions related to the treatment of opioid addiction H.R. 3014: Medical Controlled Substances Transportation Act of 2015 - Provisions related to the transport of controlled substances by physicians in certain situations H.R. 3537: Synthetic Drug Control Act of 2015 - Provisions related to amending the Controlled Substances Analogue Act and the legislative scheduling of molecules used in legitimate medical research H.R. 3680: Co-Prescribing to Reduce Overdoses Act of 2015 - Provisions related to the prescribing of opioid overdose reversal drug to at-risk patients H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act of 2015 - Provisions related to amending and withdrawing funding from the Affordable Care Act The Regenerative Medicine Regulatory Improvement Act (discussion draft) - Provisions related to creating a new regulatory pathway to speed the approval of certain stem cell treatments Kids Count Act of 2015 (discussion draft) - Provisions for incentivizing pediatric rare disease drug development ADF Incentive Act of 2015 (discussion draft) - Provisions providing manufacturers an incentive to develop abuse deterrent formulations (ADF) of controlled substances Breakpoints (discussion draft) - Provisions relating to the updating of breakpoint information for antibiotics on an FDA managed website Drug Supply Chain Security Act issues including the Charitable Donation Exemption Discussion of Reforms to the Pediatric Research Equity Act (PREA) and Best Pharmaceuticals for Children Act (BPCA) Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues Food and Drug Administration Proposed rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985) - Provisions related to product labeling changes and related procedures Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability; Proposed rules [CMS-2390-P] - Provisions related to 340B program Senate HELP Committee innovation agenda - Provisions related to biopharmaceutical discovery and development and FDA policy Proposed HRSA 340B program mega-guidance - Provisions related to 340B program Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Physician Payment Sunshine Act implementation issues, such as Open Payments System issues 340B Drug Discount Program policy issues General FDA advocacy Prescription Drug User Fee Act (PDUFA) negotiation and reauthorization Biopharmaceutical and medical innovation policy issues Drug development ecosystem policy issues Drug cost and pricing policy issues Transparency policy issues NIH Funding policy issues Precision Medicine Initiative Biomarker proposed legislation - Draft legislation related to developing a new approval pathway for biomarkers Rogue Internet Pharmacy policy issues Prescription drug abuse policy issues Drug compounding policy issues Nomination of Robert Califf to FDA Commissioner

Client expense: $3,820,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

H.R.6-21st Century Cures Act H.R.33-Protecting Volunteer Firefighters and Emergency Responders Act H.R.203-Clay Hunt Suicide Prevention for American Veterans Act H.R.293-To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes. H.R.398-Trafficking Awareness Training for Health Care Act H.R.639-Improving Regulatory Transparency for New Medical Therapies Act H.R.647-Access to Life-Saving Trauma Care for All Americans Act H.R.648-Trauma Systems and Regionalization of Emergency Care Reauthorization Act H.R.836-Health Care Safety Net Enhancement Act H.R.876-Notice of Observation Treatment and Implication for Care Eligibility (NOTICE) Act H.R.1190-Protecting Seniors Access to Medicare Act of 2015 H.R.1571-Improving Access to Medicare Coverage Act of 2015 H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1786-James Zadroga 9/11 Health and Compensation Reauthorization Act H.R.1818-Veteran Emergency Medical Technician Support Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.2050-Middle Class Health Benefits Tax Repeal Act of 2015 H.R.2366-Field EMS Modernization and Innovation Act H.R.2603-Saving Lives, Saving Costs Act H.R.2646-Helping Families in Mental Health Crisis Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015 H.R.3379-Airplane Kids In Transit Safety (KITS) Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 H.R.3681-Improving Access to Emergency Psychiatric Care Act H.R.3682-Reducing Employer Burdens, Unleashing Innovation, and Labor Development Act of 2015 H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R.3770-End Surprise Billing Act of 2015 H.R.4059-Medicare Choices Empowerment and Protection Act H.R.4150-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act S.141-Protecting Seniors Access to Medicare Act of 2015 S.167-Clay Hunt Suicide Prevention for American Veterans Act S.425-Homeless Veterans' Reintegration Programs Reauthorization Act of 2015 S.453-Veteran Emergency Medical Technician Support Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.599-Improving Access to Emergency Psychiatric Care Act S.707-Opioid Overdose Reduction Act of 2015 S.711-Mental Health First Act of 2015 S.763-Trauma Systems and Regionalization of Emergency Care Reauthorization Act S.810-SGR Repeal and Medicare Provider Payment Modernization Act of 2015 S.884-Health Care Safety Net Enhancement Act S.843-Improving Access to Medicare Coverage Act of 2015 S.928-James Zadroga 9/11 Health and Compensation Reauthorization Act S.993-Comprehensive Justice and Mental Health Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015 S.1450-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act S.1452-Veterans Emergency Health Safety Net Expansion Act of 2015 S.1475-Saving Lives, Saving Costs Act S.1549-Care Planning Act of 2015 S.1648-Rural Emergency Acute Care Hospital (REACH) Act S.1654-Overdose Prevention Act S.1693-To amend title 38, United States Code, to expand eligibility for reimbursement for emergency medical treatment to certain veterans that were unable to receive care from the Department of Veterans Affairs in the 24-month period preceding the furnishing of such emergency treatment, and for other purposes. S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015 S.1893-Mental Health Awareness and Improvement Act of 2015 S.1945-Mental Health Reform Act of 2015 S.2002-Mental Health and Safe Communities Act of 2015 S.2045-Middle Class Health Benefits Tax Repeal Act of 2015 S.2297-Medicare Choices Empowerment and Protection Act

Client expense: $374,793 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.159-Stop Exploitation Through Trafficking Act H.R.181-Justice for Victims of Trafficking Act H.R.246-To improve the response to victims of child sex trafficking H.R.285-Stop Advertising Victims of Exploitation (SAVE) Act H.R.350-Human Trafficking Prevention, Intervention and Recovery Act H.R.357-Human Trafficking Prevention Act H.R.398-Trafficking Awareness Training for Health Care Act H.R.460-Human Trafficking Detection Act H.R.468-Enhancing Services for Runaway and Homeless Victims for Youth Trafficking Act H.R.469-Strengthening Child Welfare Response to Trafficking Act H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.514-Human Trafficking Prioritization Act H.R.515-International Megans Law to Prevent Demand for Child Sex H.R.1854-Comprehensive Justice and Mental Health Act of 2015 H.R.1877-Mental Health First Aid Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 S.178-Justice for Victims of Trafficking Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.529-Combatting Human Trafficking Act of 2015 S.623-Human Trafficking Detection Act of 2015 S.642-Human Trafficking Survivors Relief and Empowerment Act of 2015 S.711-Mental Health First Act of 2015 S.993-Comprehensive Justice and Mental Health Act of 2015 S.1446-SOAR to Health and Wellness Act of 2015

Client expense: $374,793 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.471-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 H.R.1821-Opioid Overdose Reduction Act of 2015 H.R.2850-Stop Overdose Stat Act of 2015 H.R.3537-Synthetic Drug Control Act of 2015 S.36-Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 S.483-Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.707-Opioid Overdose Reduction Act of 2015 S.1327-Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act S.1654-Overdose Prevention Act

Client expense: $374,793 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health and Human Services Appropriations - In support of increased funding for the Department of Health and Human Services including National Institutes of Health research programs and Title VII and Title VIII funding; Poison Control Centers and programs for teaching and research at academic medical centers. In support of the NIH peer review system and continued support of NIH funding.In support of full restoration of NIH funding. In support of funding for National Institute for Occupational Safety and Health. In support of funding for Agency for Healthcare Research and Quality. In support of extension for 340B Program. In support of 21st Century Cures Initiative. In support of H.R.2124 and S.1148, the Resident Physician Shortage Act. In opposition to H.R.3292, the Medicare IME Pool Act. In support of retaining Department of Health and Human Services salary limit at Executive Level III. In support of amendment to H.R.1314, the Bipartisan Budget Act, related to Medicare Hospital Outpatient Departments site neutral provisions. In support of amendment to H.R.3537, the Synthetic Drug Control Act, related to research.

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 3762: Restoring Americans Healthcare Freedom Reconciliation Act of 2015, including Senate amendments related to drug importation, data exclusivity for biologics, and Medicare drug rebates. P.L. 114-113: "Consolidated Appropriations Act" with respect to the Protecting Americans from Tax Hikes Act and HHS study on prescription drug pricing. Education about the 340(b) drug discount program. H.R. 3537: Synthetic Drug Control Act of 2015. H.R. 6: 21st Century Cures Act. H.R. 2841: Fair Access for Safe and Timely Generics Act. James Zadroga 9/11 Health and Compensation Reauthorization. H.R. 3513: Prescription Drug Affordability Act of 2015. Education about the value of innovative new medicines.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE